Mylan Says PPI Formulary Impact Unclear As Omeprazole Options Increase
This article was originally published in The Tan Sheet
Executive Summary
Prescription proton pump inhibitor manufacturers are becoming increasingly wary of the effect Prilosec OTC will have on the formulary status of generic offerings